1
|
Djikic-Stojsic T, Bret G, Blond G, Girard N, Le Guen C, Marsol C, Schmitt M, Schneider S, Bihel F, Bonnet D, Gulea M, Kellenberger E. The IMS Library: from IN-Stock to Virtual. ChemMedChem 2024; 19:e202400381. [PMID: 39031900 DOI: 10.1002/cmdc.202400381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2024] [Revised: 06/18/2024] [Accepted: 06/19/2024] [Indexed: 07/22/2024]
Abstract
A chemical library is a key element in the early stages of pharmaceutical research. Its design encompasses various factors, such as diversity, size, ease of synthesis, aimed at increasing the likelihood of success in drug discovery. This article explores the collaborative efforts of computational and synthetic chemists in tailoring chemical libraries for cost-effective and resource-efficient use, particularly in the context of academic research projects. It proposes chemoinformatics methodologies that address two pivotal questions: first, crafting a diverse panel of under 1000 compounds from an existing pool through synthetic efforts, leveraging the expertise of organic chemists; and second, expanding pharmacophoric diversity within this panel by creating a highly accessible virtual chemical library. Chemoinformatics tools were developed to analyse initial panel of about 10,000 compounds into two tailored libraries: eIMS and vIMS. The eIMS Library comprises 578 diverse in-stock compounds ready for screening. Its virtual counterpart, vIMS, features novel compounds guided by chemists, ensuring synthetic accessibility. vIMS offers a broader array of binding motifs and improved drug-like characteristics achieved through the addition of diverse functional groups to eIMS scaffolds followed by filtering of reactive or unusual structures. The uniqueness of vIMS is emphasized through a comparison with commercial suppliers' virtual chemical space.
Collapse
Affiliation(s)
- Teodora Djikic-Stojsic
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Guillaume Bret
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Gaëlle Blond
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Nicolas Girard
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Clothilde Le Guen
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
- Inovarion, 251 rue St Jacques, Paris, 75005, France
| | - Claire Marsol
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Martine Schmitt
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Séverine Schneider
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Frederic Bihel
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Dominique Bonnet
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Mihaela Gulea
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| | - Esther Kellenberger
- Laboratoire d'Innovation Thérapeutique, UMR7200 CNRS - Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, Illkirch-Graffenstaden, 67400, France
| |
Collapse
|
2
|
Winyakul C, Phutdhawong W, Tamdee P, Sirirak J, Taechowisan T, Phutdhawong WS. 2,5-Diketopiperazine Derivatives as Potential Anti-Influenza (H5N2) Agents: Synthesis, Biological Evaluation, and Molecular Docking Study. Molecules 2022; 27:molecules27134200. [PMID: 35807445 PMCID: PMC9268516 DOI: 10.3390/molecules27134200] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2022] [Revised: 06/24/2022] [Accepted: 06/25/2022] [Indexed: 01/14/2023] Open
Abstract
2,5-Diketopiperazine derivatives, consisting of benzylidene and alkylidene substituents at 3 and 6 positions, have been considered as a core structure for their antiviral activities. Herein, the novel N-substituted 2,5-Diketopiperazine derivatives were successfully prepared and their antiviral activities against influenza virus were evaluated by monitoring viral propagation in embryonated chicken eggs. It was found that (3Z,6Z)-3-benzylidene-6-(2-methyl propylidene)-4-substituted-2,5-Diketopiperazines (13b–d), (3Z,6E)-3-benzylidene-6-(2-methylpropyli dene)-1-(1-ethyl pyrrolidine)-2,5-Diketopiperazine (14c), and Lansai-C exhibited negative results in influenza virus propagation at a concentration of 25 µg/mL. Additionally, molecular docking study revealed that 13b–d and 14c bound in 430-cavity of neuraminidase from H5N2 avian influenza virus and the synthesized derivatives also strongly interacted with the key amino acid residues, including Arg371, Pro326, Ile427, and Thr439.
Collapse
Affiliation(s)
- Chanakan Winyakul
- Department of Chemistry, Faculty of Science, Silpakorn University, Nakorn Pathom 73000, Thailand; (C.W.); (P.T.); (J.S.)
| | - Weerachai Phutdhawong
- Department of Chemistry, Faculty of Liberal Arts and Science, Kasetsart University, Kamphaengsaen Campus, Nakorn Pathom 73140, Thailand;
| | - Poomipat Tamdee
- Department of Chemistry, Faculty of Science, Silpakorn University, Nakorn Pathom 73000, Thailand; (C.W.); (P.T.); (J.S.)
| | - Jitnapa Sirirak
- Department of Chemistry, Faculty of Science, Silpakorn University, Nakorn Pathom 73000, Thailand; (C.W.); (P.T.); (J.S.)
| | - Thongchai Taechowisan
- Department of Microbiology, Faculty of Science, Silpakorn University, Nakorn Pathom 73000, Thailand;
| | - Waya S. Phutdhawong
- Department of Chemistry, Faculty of Science, Silpakorn University, Nakorn Pathom 73000, Thailand; (C.W.); (P.T.); (J.S.)
- Correspondence: ; Tel.: +66-34-255797
| |
Collapse
|
3
|
Bojarska J, Mieczkowski A, Ziora ZM, Skwarczynski M, Toth I, Shalash AO, Parang K, El-Mowafi SA, Mohammed EHM, Elnagdy S, AlKhazindar M, Wolf WM. Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold. Biomolecules 2021; 11:1515. [PMID: 34680148 PMCID: PMC8533947 DOI: 10.3390/biom11101515] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2021] [Revised: 10/11/2021] [Accepted: 10/12/2021] [Indexed: 12/12/2022] Open
Abstract
Cyclic dipeptides, also know as diketopiperazines (DKP), the simplest cyclic forms of peptides widespread in nature, are unsurpassed in their structural and bio-functional diversity. DKPs, especially those containing proline, due to their unique features such as, inter alia, extra-rigid conformation, high resistance to enzyme degradation, increased cell permeability, and expandable ability to bind a diverse of targets with better affinity, have emerged in the last years as biologically pre-validated platforms for the drug discovery. Recent advances have revealed their enormous potential in the development of next-generation theranostics, smart delivery systems, and biomaterials. Here, we present an updated review on the biological and structural profile of these appealing biomolecules, with a particular emphasis on those with anticancer properties, since cancers are the main cause of death all over the world. Additionally, we provide a consideration on supramolecular structuring and synthons, based on the proline-based DKP privileged scaffold, for inspiration in the design of compound libraries in search of ideal ligands, innovative self-assembled nanomaterials, and bio-functional architectures.
Collapse
Affiliation(s)
- Joanna Bojarska
- Faculty of Chemistry, Institute of General & Inorganic Chemistry, Technical University of Lodz, 90-924 Lodz, Poland;
| | - Adam Mieczkowski
- Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw, Poland;
| | - Zyta M. Ziora
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia; (Z.M.Z.); (I.T.)
| | - Mariusz Skwarczynski
- School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia; (M.S.); (A.O.S.)
| | - Istvan Toth
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, QLD 4072, Australia; (Z.M.Z.); (I.T.)
- School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia; (M.S.); (A.O.S.)
- School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia
| | - Ahmed O. Shalash
- School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia; (M.S.); (A.O.S.)
| | - Keykavous Parang
- Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, School of Pharmacy, Chapman University, Irvine, CA 92618, USA; (K.P.); (S.A.E.-M.); (E.H.M.M.)
| | - Shaima A. El-Mowafi
- Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, School of Pharmacy, Chapman University, Irvine, CA 92618, USA; (K.P.); (S.A.E.-M.); (E.H.M.M.)
| | - Eman H. M. Mohammed
- Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Harry and Diane Rinker Health Science Campus, School of Pharmacy, Chapman University, Irvine, CA 92618, USA; (K.P.); (S.A.E.-M.); (E.H.M.M.)
| | - Sherif Elnagdy
- Botany Department, Faculty of Science, Cairo University, Giza 12613, Egypt; (S.E.); (M.A.)
| | - Maha AlKhazindar
- Botany Department, Faculty of Science, Cairo University, Giza 12613, Egypt; (S.E.); (M.A.)
| | - Wojciech M. Wolf
- Faculty of Chemistry, Institute of General & Inorganic Chemistry, Technical University of Lodz, 90-924 Lodz, Poland;
| |
Collapse
|
4
|
Maujean T, Girard N, Ganesan A, Gulea M, Bonnet D. Three cheers for nitrogen: aza-DKPs, the aza analogues of 2,5-diketopiperazines. RSC Adv 2020; 10:43358-43370. [PMID: 35519699 PMCID: PMC9058409 DOI: 10.1039/d0ra09457a] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2020] [Accepted: 11/10/2020] [Indexed: 11/22/2022] Open
Abstract
Nitrogen-containing heterocycles represent a major source of pharmacological probes and drug candidates. To extend their molecular diversity and their potential biological activities, it is of importance to design and synthesize new N-heterocyclic scaffolds. Therefore, aza-diketopiperazines (aza-DKPs), the aza analogues of well-known 2,5-diketopiperazines (DKPs), emerged as a promising new scaffold. Although the first synthesis of an aza-DKP dates from 1951, significant developments have been made during the last decade. This feature article summarizes the different synthetic strategies to access and functionalise aza-DKPs. Their biological properties and potential applications in medicinal chemistry and drug discovery are discussed as well.
Collapse
Affiliation(s)
- Timothé Maujean
- Université de Strasbourg, CNRS, Laboratoire d'Innovation Thérapeutique, LabEX MEDALIS, Faculté de Pharmacie LIT UMR 7200 Strasbourg F-67000 France
| | - Nicolas Girard
- Université de Strasbourg, CNRS, Laboratoire d'Innovation Thérapeutique, LabEX MEDALIS, Faculté de Pharmacie LIT UMR 7200 Strasbourg F-67000 France
| | - A Ganesan
- School of Pharmacy, University of East Anglia Norwich Research Park Norwich NR4 7TJ UK
| | - Mihaela Gulea
- Université de Strasbourg, CNRS, Laboratoire d'Innovation Thérapeutique, LabEX MEDALIS, Faculté de Pharmacie LIT UMR 7200 Strasbourg F-67000 France
| | - Dominique Bonnet
- Université de Strasbourg, CNRS, Laboratoire d'Innovation Thérapeutique, LabEX MEDALIS, Faculté de Pharmacie LIT UMR 7200 Strasbourg F-67000 France
| |
Collapse
|